New bladder cancer drug tested for safety in early trial
NCT ID NCT05375903
Summary
This early-stage study tested the safety of a new drug called UGN-301 for people with recurring non-muscle invasive bladder cancer. The drug was delivered directly into the bladder, both by itself and combined with other treatments. The main goal was to find a safe dose and understand how the body processes the drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arkansas Urology
Little Rock, Arkansas, 72211, United States
-
Clinical Research Solutions
Middleburg Heights, Ohio, 44130, United States
-
Florida Urology Partners, LLC
Tampa, Florida, 33615, United States
-
Hospital Clinic de Barcelona Instituto Clinic de Nefrologia y Urologia (ICNU)
Barcelona, 08036, Spain
-
I.R.C.C.S. Ospedale San Raffaele
Milan, Italy
-
Istituto Oncologico Veneto
Padua, Italy
-
Johns Hopkins University
Baltimore, Maryland, 21287, United States
-
Manhattan Medical Research
New York, New York, 10016, United States
-
NEXT Oncology IOB- Hospital Quironsalud Barcelona
Barcelona, 08023, Spain
-
NEXT Oncology- Hospital Quironsalud Mardrid
Madrid, 28223, Spain
-
National Tumor Institute Fondazione G. Pascale
Naples, Italy
-
Penn State Milton S Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
-
UCLA - University of California
Los Angeles, California, 90095, United States
Conditions
Explore the condition pages connected to this study.